Gujarat Kidney & Super Speciality Ltd
Gujarat Kidney | 544666
GKSL - Share Price Chart
Stock Performance
Ratios
About Company
- Gujarat Kidney And Super Speciality Limited was incorporated under the name and style of Vihaan Medicare Private Limited', a private limited company, dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre
- Subsequently, the Company name was changed to Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad
- Further, Company' status was changed to a public limited company and the name of Company was changed to Gujarat Kidney and Super Speciality Limited' dated November 24, 2023 by the ROCs, Ahmedabad
- The Company operate a chain of mid-sized multispecialty healthcare institution and is engaged in providing comprehensive medical services, including inpatient and outpatient care, surgical procedures, diagnostic services, and emergency care
- It is one of the regional healthcare companies located in the central region of state of Gujarat
- The Company categorize its healthcare services as secondary services (which are surgical services) and Tertiary Services (which are super speciality surgical services)
- The Hospital operates with a commitment to delivering high-quality healthcare through advanced medical technology and a team of highly skilled professionals
- The Company established and commenced the operations of its first hospital under the name of Gujarat Kidney Hospital' at Vadodara, Gujarat in 2014 and later on expanded the bed capacity from 15 to 65 in 2018, with the establishment of 5 sub-specialities in the Uro Department, viz
- , endourology, urologic oncology, paediatric urology, reconstructive urology, and laparoscopic urology at the Gujarat Kidney Hospital
- In 2019, it set up an in-house interventional cardiology department under the name of Gujarat Heart Care Unit' for offering invasive cardiology services
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Top Gainers
Group Stocks
Frequently Asked Questions
What is Share Price of Gujarat Kidney & Super Speciality Ltd?
The current share price of Gujarat Kidney & Super Speciality Ltd (Gujarat Kidney) is ₹152.70. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Gujarat Kidney & Super Speciality Ltd?
The Price-to-Earnings (P/E) ratio of Gujarat Kidney & Super Speciality Ltd is 152.70. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Gujarat Kidney & Super Speciality Ltd?
Gujarat Kidney & Super Speciality Ltd has a 52-week high of ₹162.22 and a 52-week low of ₹98.36. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Gujarat Kidney & Super Speciality Ltd?
Gujarat Kidney & Super Speciality Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Gujarat Kidney & Super Speciality Ltd?
The Earnings Per Share (EPS) of Gujarat Kidney & Super Speciality Ltd is ₹2.01. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Gujarat Kidney & Super Speciality Ltd?
Gujarat Kidney & Super Speciality Ltd has a Return on Equity (ROE) of 16.70%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
